United States Autoimmune Disease Diagnostics Market Size & Outlook, 2025-2029
United States Autoimmune Disease Diagnostics Market Size
According to Straits Research analysis, The United States Autoimmune Disease Diagnostics Market was valued at USD 1778.64 Million in 2024 and is projected to reach USD 2505.46 Million by 2029, expanding at a CAGR of 7.2% during the forecast period. This growth is primarily propelled by factors like the increasing prevalence of autoimmune diseases, advancements in diagnostic technologies and extensive research activities in this sector. Specifically, industries geared towards biotechnology, healthcare, and pharmaceuticals are driving demand. Market trends, including the integration of advanced technologies like artificial intelligence in diagnostics and personalized medicinal approaches, offer potential growth opportunities. Implementing sustainable laboratory practices for diagnostics is another emerging trend. The United States, with its robust healthcare system and research infrastructure, positions itself advantageously, paving the way for continued growth and leadership in the global autoimmune disease diagnostics market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Autoimmune Disease Diagnostics Market Highlights
- By segment, Consumables & Assay Kits emerged as the largest Product in terms of market size in 2024.
- Consumables & Assay Kits is anticipated to remain the most attractive Product segment, recording the fastest growth during the forecast period.
- United States accounted for 32.28% of the global autoimmune disease diagnostics market size in 2024.
- By 2029, United States is expected to remain the top global market in terms of size.
- Within North America, United States is forecasted to dominate the regional autoimmune disease diagnostics market size by 2029.
- Canada will be the fastest-growing market in North America, projected to achieve USD 24106 Million by 2029.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2029 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2029 |
| Market Size In 2024 | USD 1778.64 Million |
| Market Size In 2029 | USD 2505.46 Million |
| Largest segment | Consumables & Assay Kits |
| Fastest segment | Consumables & Assay Kits |
| Units | Revenue in USD Million |
| CAGR | 7.2% (2025-2029) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United States Autoimmune Disease Diagnostics Market Share By Product
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Product |
|
| Test type |
|
| Target disease |
|
| Systemic Autoimmune Disease, by Type |
|
| Localized Autoimmune Disease, by Type |
|
| End User |
|
United States Autoimmune Disease Diagnostics Market By Product 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Autoimmune Disease Diagnostics Market By Test type 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Autoimmune Disease Diagnostics Market By Target disease 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Autoimmune Disease Diagnostics Market By Systemic Autoimmune Disease, by Type 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Autoimmune Disease Diagnostics Market By Localized Autoimmune Disease, by Type 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Autoimmune Disease Diagnostics Market By End User 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
